In April 2018, the AACR and Cancer Research UK (CRUK) announced a new international alliance aimed toward accelerating the pace of progress against cancer. The announcement was made jointly by AACR President (2017-2018) Michael A. Caligiuri, MD, FAACR, and CRUK Chief Clinician Charles Swanton, MD, PhD, FRCP, during the opening ceremony at the AACR Annual Meeting 2018.
The alliance between the world’s largest professional organization dedicated to advancing cancer research and the world’s largest fundraising medical research charity will build transatlantic collaborations by establishing training and exchange programs, convening international meetings and workshops, and uniting the community to influence global research policy.
The AACR collaborated with 12 international cancer research organizations in 2018 to develop the following joint conferences, educational workshops, and symposia:
The AACR worked with additional organizations while developing joint sessions for the following international conferences:
In 2018, the AACR offered an expanded slate of opportunities to international investigators to travel to Chicago, Illinois, and participate in the AACR Annual Meeting—the touchstone event for the global cancer research community—while also offering opportunities for AACR members to present their work abroad:
International AACR Collaborators in 2018 |
---|
A.C. Camargo Cancer Center |
Association for Cancer Immunotherapy (CIMT) |
Cancer Science Institute of Singapore (CSI) |
Chinese Society for Clinical Oncology (CSCO) |
Cancer Research UK (CRUK) |
European Academy of Tumor Immunotherapy (EATI) |
European Association for Cancer Research (EACR) |
European Cancer Organisation (ECCO) |
European Medicines Agency (EMA) |
European Organisation for Research and Treatment of Cancer (EORTC) |
European Society for Medical Oncology (ESMO) |
Israel Society for Cancer Research (ISCR) |
Japanese Cancer Association (JCA) |
Korean Cancer Association (KCA) |
Latin American Cooperative Oncology Group (LACOG) |
Medical Oncology Group of Australia (MOGA) |
While in Jerusalem in October to attend the conference on “The Cutting Edge of Contemporary Cancer Research”—a joint venture between the AACR, the European Association for Cancer Research (EACR), and the Israel Society for Cancer Research (ISCR)—AACR CEO Margaret Foti, PhD, MD (hc) (center), met with Israeli President Reuven Rivlin (right) and First Lady Nechama Rivlin at their residence. During her remarks, Dr. Foti highlighted the progress that has been made against cancer and the importance of international collaborations to advancing that progress. The meeting was coordinated by Miri Ziv (left), Director General of the Israel Cancer Association; in her remarks, Dr. Foti acknowledged Ms. Ziv for her contributions to international cancer research and advocacy.
The AACR joined ten other cofounding partner organizations to mark World Cancer Research Day on September 24. The goal of World Cancer Research Day was to raise awareness of the extraordinary impact of cancer science and to acknowledge the contributions made by cancer researchers to reduce the global burden of cancer.